Clinical Trials Directory

Trials / Unknown

UnknownNCT05432050

Bispectral Index and Patient State Index During General Anesthesia With Remimazolam

Bispectral Index and Patient State Index During General Anesthesia With Remimazolam: a Prospective Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers

Summary

The aim of this study is to compare the bispectral index (BIS) and patient state index (PSI) during general anesthesia using remimazolam. The infusion rate of remimazolam is 6-12mg/kg/h during induction of anesthesia and 1-2mg/kg/h during maintenance of anesthesia. To calculate the fraction, the sum of times when BIS\<60 and PSI \<50 will be divided by the time from the loss of consciousness during induction of anesthesia to fully awake during emergence. We will compare the fraction of BIS \<60 and the fraction of PSI \<50 to find if there is some difference between the two depth of anesthesia monitoring devices during remimazolam anesthesia.

Conditions

Interventions

TypeNameDescription
DEVICEBispectral index and Patient state index monitoringThe depth of anesthesia will be monitored with both the bispectral index and patient state index at the same time.

Timeline

Start date
2022-07-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2022-06-27
Last updated
2022-07-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05432050. Inclusion in this directory is not an endorsement.